How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,502 results for

Fetal Tachycardia

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Treatment of fetal supraventricular tachycardia by intra-amniotic administration of digoxin. (Abstract)

Treatment of fetal supraventricular tachycardia by intra-amniotic administration of digoxin. Fetal arrhythmias occur in as many as 1- 3% of pregnancies1 . Supraventricular tachycardia (SVT) accounts for about 66-90% of fetal tachyarrhythmia2 . First-line therapy has not been determined in randomized trials, but digoxin has been considered the first-choice drug. Flecainide and sotalol have been advocated as second-choice drugs, though flecainide might be more effective as a first-line treatment3

2019 Ultrasound in Obstetrics and Gynecology

2. Morphine-induced supraventricular tachycardia in near-term fetus Full Text available with Trip Pro

Morphine-induced supraventricular tachycardia in near-term fetus Fetal supraventricular tachycardia (SVT), characterized by fetal heart rate between 220 and 260 bpm, is a rare but most commonly encountered fetal cardiac arrhythmia in pregnancy that may be associated with adverse perinatal outcome.We describe a 36/6 week near term fetus who presented morphine-induced SVT after maternal treatment of a renal colic. Following emergency cesarean section, the neonate had resolution of symptoms.The (...) pathophysiology of morphine-related SVT, previously documented in experimental animal models, and for the first time reported in the human fetus, is presented.

2018 Italian journal of pediatrics

3. Guidelines on Supraventricular Tachycardia (for the management of patients with) Full Text available with Trip Pro

12.3.1 Atrial septal defect 42 12.3.2 Ebstein's anomaly 42 12.3.3 Transposition of the great arteries (dextro-transposition of the great arteries) after atrial switch operation (Mustard or Senning) 42 12.3.4 Tetralogy of Fallot 43 12.3.5 Fontan repairs 43 13 Supraventricular tachycardia in the paediatric population 43 13.1 Foetal arrhythmias 43 14 Supraventricular tachycardia in pregnancy 43 14.1 Maternal, obstetric, and offspring risk 44 14.2 Therapy 44 14.2.1 Antiarrhythmic drugs 44 14.2.2 (...) Guidelines on Supraventricular Tachycardia (for the management of patients with) 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie

2019 European Society of Cardiology

4. Potential utility of pulsed Doppler for prenatal diagnosis of fetal ventricular tachycardia secondary to long QT syndrome. Full Text available with Trip Pro

Potential utility of pulsed Doppler for prenatal diagnosis of fetal ventricular tachycardia secondary to long QT syndrome. 28741754 2018 10 19 2018 10 19 1469-0705 51 5 2018 May Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology Ultrasound Obstet Gynecol Potential utility of pulsed-wave Doppler for prenatal diagnosis of fetal ventricular tachycardia secondary to long QT syndrome. 697-699 10.1002/uog.18819 Miyoshi (...) , 5-7-1 Fujishiro-dai, Suita, Osaka, 565-8565, Japan. Ikeda T T Department of Obstetrics and Gynecology, Mie University, Tsu, Japan. eng Case Reports Letter England Ultrasound Obstet Gynecol 9108340 0960-7692 0 Anti-Arrhythmia Agents 7487-88-9 Magnesium Sulfate IM Adult Anti-Arrhythmia Agents administration & dosage Cesarean Section Electrocardiography Female Fetal Heart diagnostic imaging Humans Long QT Syndrome diagnostic imaging drug therapy Magnesium Sulfate administration & dosage Pregnancy

2017 Ultrasound in Obstetrics and Gynecology

5. Transient Fetal Tachycardia After Intravenous Diphenhydramine Administration. (Abstract)

Transient Fetal Tachycardia After Intravenous Diphenhydramine Administration. Fetal tachycardia is attributable to a variety of etiologies, including an untreated maternal medical condition or an indicator of potential fetal compromise. Maternal medication administration may also affect the fetal heart rate.A 28-year-old nulliparous patient at 41 weeks of gestation was treated for pruritus with intravenous diphenhydramine after epidural administration of fentanyl. Within 14 minutes, the fetal (...) heart rate increased from a baseline of 155 beats per minute (bpm) to more than 200 bpm while maintaining moderate variability. This was accompanied by an increase in uterine contractions occurring every 1.5 minutes. The fetal tachycardia lasted 51 minutes; several hours later, a healthy neonate was delivered.Diphenhydramine may produce transient fetal tachycardia as well as increased maternal uterine activity.

2017 Obstetrics and Gynecology

6. Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

heart rate up to 300 beats per minute due to supraventricular tachyarrhythmia (SVA) in the unborn baby (fetus). Although fetal SVA, including AF and other forms of SVT, is the most common cause of intended in-utero fetal therapy, our knowledge of drug effects on the baby and the co-treated mother is still limited. The Fetal Atrial Flutter and Supraventricular Tachycardia (FAST) Therapy Trial is a prospective multi-center trial to address this knowledge gap in order to guide future patient management (...) Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2017 Clinical Trials

7. Postnatal Outcomes of Fetal Supraventricular Tachycardia: a Multicenter Study. (Abstract)

Postnatal Outcomes of Fetal Supraventricular Tachycardia: a Multicenter Study. Supraventricular tachycardia (SVT), the most common fetal tachycardia, can be difficult to manage in utero. We sought to better understand predictors of the postnatal clinical course in neonates who experienced fetal SVT. We hypothesized that fetuses with hydrops or those with refractory SVT (failure of first-line SVT therapy) are more likely to experience postnatal SVT. This was a retrospective multicenter cohort (...) study of subjects diagnosed with fetal SVT between 2006 and 2014. Fetuses with structural heart disease were excluded. Descriptive comparative statistics and univariate analysis with logistic regression were utilized to determine factors that most strongly predicted postnatal SVT and preterm delivery. The cohort consisted of 103 subjects. Refractory SVT was found in 37% (N = 38) of the cohort with this group more likely to be delivered prematurely (median = 36 vs. 37.5 weeks, p = 0.04). Refractory

2017 Pediatric Cardiology

8. Fetal Tachycardia

Tachycardia , FHR Tachycardia From Related Chapters II. Definition >160 bpm III. Mild Fetal Tachycardia (FHR 160-180 bpm) Usually benign if normal Other causes Maternal fever, dehydration or anxiety Maternal ketosis Medications s (e.g. ) medications (e.g. ) Fetal movement Preterm Fetus Maternal Maternal IV. Significant Fetal Tachycardia (FHR >180 bpm) (especially if maternal fever) Fetal arrhythmia or congenital defect (FHR >200 bpm) V. References Bailey (2000) ALSO, E:1-13 Gabbe (2002) Obstetrics, p. 395 (...) foetale tachycardie , tachycardiie, foetaal , tachycardie foetaal German fetale Tachykardie , Tachykardie fetal Japanese 胎児頻脈 , タイジヒンミャク English fetal tachycardia (diagnosis) , fetal tachycardia , Tachycardia fetal , Foetal tachycardia , Tachycardia foetal , Fetal Tachycardia , Baseline Fetal Tachycardia , Fetal tachycardia , Fetal tachycardia (disorder) Czech Tachykardie u plodu , Fetální tachykardie Hungarian Tachycardia, foetalis , Magzati tachycardia , Foetalis tachycardia , Magzati szapora

2018 FP Notebook

9. A prospective cohort study of fetal heart rate monitoring: deceleration area is predictive of fetal acidemia Full Text available with Trip Pro

and morbidities in term infants. We further identified patterns prior to delivery, alone or in combination, predictive of acidemia and neonatal morbidity.This was a prospective cohort study of 8580 women from 2010 through 2015. Patients were all consecutive women laboring at ≥37 weeks' gestation with a singleton cephalic fetus. Electronic fetal monitoring patterns during the 120 minutes prior to delivery were interpreted in 10-minute epochs. Interpretation included the category system and individual (...)  minutes of tachycardia had the greatest discriminative ability for neonatal morbidity (area under the receiver operating characteristic curves, 0.77; 95% confidence interval, 0.75-0.79). Once the threshold of deceleration area is reached the number of cesareans needed-to-be performed to potentially prevent 1 case of acidemia and morbidity is 5 and 6, respectively.Deceleration area is the most predictive electronic fetal monitoring pattern for acidemia, and combined with tachycardia for significant

2018 EvidenceUpdates

10. ShortGuide: Fetal movements

changes–peak activity in afternoon and evening from 20 weeks o Activity–sleep cycles occur day and night for 20–40 minute; rarely exceed 90 minutes in healthy fetus 11 · No definite conclusions about normal fetal movements in multiple pregnancies 16 Factors affecting fetal movements · Patterns change as fetus develops o Movements become more organised (increased motor co-ordination resulting in slower more powerful gross movements) 14 · External stimuli (e.g. acoustic stimuli 17 may increase, decrease (...) consider referral for obstetric ultrasound scan (USS) to assess growth and exclude fetal neuromuscular condition Decreased or abnormal fetal movements Aspect Consideration Clinical assessment · Perform assessment of woman and fetus as soon as possible within two hours of presentation including: o Review current pregnancy, medical and previous obstetric history o Review any previous USS for fetal growth assessment as plotted on growth charts 5 o Consider woman’s risk factors for fetal compromise

2019 Queensland Health

11. Intrapartum fetal surveillance

intrapartum CTG is unclear and may be related to the fetus moving less Normal intrapartum Term 1 · Baseline FHR of 110–160 bpm · Normal baseline variability present · Accelerations may or may not be present · No decelerations Preterm 28 · Baseline fetal heart at 20–24 weeks averages 155 bpm decreasing with advancing gestational age · Baseline rate will be around the upper limits of normal o Tachycardia reduces with gestational age · Baseline variability may be reduced due to tachycardia in preterm fetus (...) . Description of normal FHR 16 Table 12. Compromised fetus 17 Table 13. Reversible causes of abnormal CTG 18 Table 14. Intrapartum fetal blood sampling 19 Table 15. Intrapartum fetal blood sampling results 20 Table 16. Paired umbilical cord sampling 21 Table 17 Cord blood sampling outcome 22 Table 18 Normal cord blood gas and lactate (at birth) 22 Queensland Clinical Guideline: Intrapartum fetal surveillance Refer to online version, destroy printed copies after use Page 7 of 30 1 Introduction The principal

2019 Queensland Health

12. Vibroacoustic stimulation for fetal assessment in labour in the presence of a nonreassuring fetal heart rate trace. Full Text available with Trip Pro

Vibroacoustic stimulation for fetal assessment in labour in the presence of a nonreassuring fetal heart rate trace. Fetal vibroacoustic stimulation (VAS) is a simple, non-invasive technique where a device is placed on the maternal abdomen over the region of the fetal head and sound is emitted at a predetermined level for several seconds. It is hypothesised that the resultant startle reflex in the fetus and subsequent fetal heart rate (FHR) acceleration or transient tachycardia following VAS (...) provide reassurance of fetal well-being. This technique has been proposed as a tool to assess fetal well-being in the presence of a nonreassuring cardiotocographic (CTG) trace during the first and second stages of labour.To evaluate the clinical effectiveness and safety of VAS in the assessment of fetal well-being during labour, compared with mock or no stimulation for women with a singleton pregnancy exhibiting a nonreassuring FHR pattern.We searched the Cochrane Pregnancy and Childbirth Group's

2013 Cochrane

13. High Dose Flecainide is the Most Effective Treatment for Fetal Supraventricular Tachycardia. (Abstract)

High Dose Flecainide is the Most Effective Treatment for Fetal Supraventricular Tachycardia. Fetal tachyarrhythmia can lead to fetal hydrops due to heart failure. Flecainide is often considered as second-line therapy when digoxin monotherapy fails, which is more likely in hydropic fetuses. Time to conversion to sinus rhythm (SR) is critical in cases presenting with hydrops.The aim of this study was to evaluate the efficacy and time to conversion to SR of transplacental treatment, especially (...) tolerated.Flecainide is highly effective in achieving SR in hydropic and nonhydropic fetuses with supraventricular tachycardia in a median time of 3 days. In our opinion, flecainide should be considered as first-line therapy in fetal supraventricular tachycardia with and without hydrops.Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

2016 Heart Rhythm

14. Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome Full Text available with Trip Pro

Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome 28491768 2019 02 26 2214-0271 3 1 2017 Jan HeartRhythm case reports HeartRhythm Case Rep Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome. 53-57 10.1016/j.hrcr.2016.09.001 Miyake Akira A Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan. Sakaguchi Heima (...) , National Cerebral and Cardiovascular Center, Osaka, Japan. eng Case Reports 2016 09 21 United States HeartRhythm Case Rep 101656239 2214-0271 Congenital long QT syndrome Fetal magnetocardiography Prenatal management Ventricular arrhythmia Ventricular tachycardia/torsades de pointes 2017 5 12 6 0 2017 5 12 6 0 2017 5 12 6 1 epublish 28491768 10.1016/j.hrcr.2016.09.001 S2214-0271(16)30106-3 PMC5420015 J Am Coll Cardiol. 2009 Nov 24;54(22):2052-62 19926013 Ultrasound Obstet Gynecol. 2009 Oct;34(4):475-80

2016 HeartRhythm Case Reports

15. Digoxin Therapy of Fetal Superior Ventricular Tachycardia: Are Digoxin Serum Levels Reliable? Full Text available with Trip Pro

Digoxin Therapy of Fetal Superior Ventricular Tachycardia: Are Digoxin Serum Levels Reliable? Despite its seldom occurrence, fetal tachycardia can lead to poor fetal outcomes including hydrops and fetal death. Management can be challenging and result in maternal adverse effects secondary to high serum drug levels required to achieve effective transplacental antiarrhythmic drug therapy.A 33-year-old woman at 33 weeks of gestation with a diagnosis of a fetal sustained superior ventricular (...) tachycardia developed chest pain, shortness of breath, and bigeminy on electrocardiogram secondary to digoxin toxicity despite subtherapeutic serum drug levels. She required supportive care with repletion of corresponding electrolyte abnormalities. After resolution of cardiac manifestations of digoxin toxicity, the patient was discharged home. The newborn was discharged at day 9 of life on maintenance amiodarone.We describe an interesting case of digoxin toxicity with cardiac manifestations of digoxin

2016 AJP Reports

16. Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols. (Abstract)

Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols. The optimal treatment for fetal supraventricular tachycardia (SVT) with 1:1 atrioventricular relationship is unclear.We compared the effectiveness of transplacental treatment protocols used in 2 centers.Pharmacologic treatment was used in 84 fetuses. Maternal oral flecainide was the primary therapy in center 1 (n = 34) and intravenous maternal digoxin in center 2 (n = 50). SVT mechanism (...) with flecainide.Flecainide was more effective than digoxin, especially when hydrops was present. No adverse fetal outcomes were attributed to flecainide.Crown Copyright © 2016. Published by Elsevier Inc. All rights reserved.

2016 Heart Rhythm

17. Novel fetal ectopic atrial tachycardia findings on cardiotocography. (Abstract)

Novel fetal ectopic atrial tachycardia findings on cardiotocography. 25612321 2016 09 13 2016 11 26 1469-0705 46 5 2015 Nov Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology Ultrasound Obstet Gynecol Novel findings of fetal ectopic atrial tachycardia by cardiotocography. 629-30 10.1002/uog.14797 Miyoshi T T Departments of Perinatology and Gynecology, National Cerebral and Cardiovascular Center, Suita, Osaka (...) Ultrasound Obstet Gynecol 9108340 0960-7692 0 Anti-Arrhythmia Agents 73K4184T59 Digoxin IM Anti-Arrhythmia Agents administration & dosage Cardiotocography Cesarean Section Digoxin administration & dosage Female Humans Infant, Newborn Male Pregnancy Pregnancy Outcome Tachycardia, Ectopic Atrial diagnostic imaging drug therapy embryology Ultrasonography 2014 12 05 2015 01 13 2015 01 15 2015 1 23 6 0 2015 1 23 6 0 2016 9 14 6 0 ppublish 25612321 10.1002/uog.14797

2015 Ultrasound in Obstetrics and Gynecology

18. Minimal Use of Fluoroscopy to Reduce Fetal Radiation Exposure during Radiofrequency Catheter Ablation of Maternal Supraventricular Tachycardia Full Text available with Trip Pro

Minimal Use of Fluoroscopy to Reduce Fetal Radiation Exposure during Radiofrequency Catheter Ablation of Maternal Supraventricular Tachycardia Electrophysiologic procedures in the young engender concern about the potential long-term effects of radiation exposure. This concern is manifold if such procedures are contemplated during pregnancy. Catheter ablations in pregnancy are indicated only in the presence of an unstable tachycardia that cannot be controlled by antiarrhythmic agents (...) . This report describes the case of an 18-year-old pregnant woman and our stratagem to minimize irradiation of the mother and the fetus.

2015 Texas Heart Institute Journal

19. Supraventricular Tachycardia: Guideline For the Management of Adult Patients With

Supraventricular Tachycardia: Guideline For the Management of Adult Patients With CLINICAL PRACTICE GUIDELINE 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Writing Committee Members* Richard L. Page, MD, FACC, FAHA, FHRS, Chair José A. Joglar, MD, FACC, FAHA, FHRS, Vice Chair Mary A. Caldwell, RN (...) 2015 and the American Heart Association Executive Committee in September 2015. The American College of Cardiology requests that this document be cited as follows: Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, EstesNAM3rd,FieldME,GoldbergerZD,HammillSC,IndikJH,LindsayBD,OlshanskyB,RussoAM,ShenW-K,TracyCM,Al-KhatibSM.2015ACC/AHA/ HRS guideline forthe managementof adultpatientswith supraventricular tachycardia: a report of the AmericanCollegeof Cardiology/AmericanHeart Association

2015 American College of Cardiology

20. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia Full Text available with Trip Pro

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies (...) . By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society , MD, FACC, FAHA, FHRS, Chair , MD, FACC, FAHA, FHRS, Vice Chair , RN, MBA, PhD, FAHA , MD, FACC, FAHA, FHRS , MD, FACC , MD , MD, FACC

2015 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>